Distal Pancreatectomy | Surgery for Tumors of the Pancreatic Body and Tail

Distal Pancreatectomy for Pancreatic Cancer

Distal pancreatectomy is an operation performed to remove tumors arising in the body or tail of the pancreas. The procedure is commonly used in the treatment of pancreatic cancer, pancreatic neuroendocrine tumors, cystic neoplasms, and other pancreatic lesions located in the distal pancreas.

Dr. Geoffrey W. Krampitz is a fellowship-trained pancreatic cancer surgeon and hepatopancreatobiliary (HPB) surgical oncologist serving patients throughout the San Francisco Bay Area. His clinical practice focuses on complex pancreatic, liver, and gastrointestinal cancer surgery, incorporating advanced minimally invasive and robotic techniques when appropriate.

Careful preoperative evaluation, multidisciplinary treatment planning, and precise surgical technique are essential to achieving safe outcomes and effective oncologic resection.

What Is a Distal Pancreatectomy?

Distal pancreatectomy is a surgical procedure that removes the body and tail of the pancreas while preserving the head of the pancreas and the duodenum.

The operation typically includes removal of:

  • the body of the pancreas

  • the tail of the pancreas

  • surrounding lymph nodes

Because the splenic artery and splenic vein run along the upper border of the pancreas, the spleen is often removed at the same time as the pancreas during standard distal pancreatectomy.

In selected patients with benign or low-grade tumors, spleen-preserving distal pancreatectomy may be possible.

Following removal of the distal pancreas, the remaining pancreatic head continues to produce digestive enzymes and hormones.

Figure. Distal Pancreatectomy.
Diagram illustrating removal of the body and tail of the pancreas. The spleen is commonly removed because the splenic artery and vein course along the pancreas, although spleen-preserving techniques may be possible in selected patients.

Conditions Treated with Distal Pancreatectomy

Distal pancreatectomy may be recommended for several conditions, including:

  • pancreatic ductal adenocarcinoma of the pancreatic body or tail

  • pancreatic neuroendocrine tumors

  • mucinous cystic neoplasms

  • intraductal papillary mucinous neoplasms (IPMN) involving the distal pancreas

  • solid pseudopapillary neoplasms

  • selected pancreatic metastases

The decision to proceed with surgery depends on tumor biology, imaging findings, and overall patient health.

Surgical Approaches

Distal pancreatectomy may be performed using open, laparoscopic, or robotic techniques, depending on tumor characteristics and patient factors.

In selected patients, minimally invasive or robotic approaches may allow improved visualization and precise dissection while maintaining strict adherence to oncologic principles.

Dr. Krampitz incorporates advanced minimally invasive and robotic techniques when appropriate for pancreatic surgery.

(This sentence can internally link to your Robotic Pancreatic Surgery page.)

Preoperative Evaluation

Patients undergoing distal pancreatectomy typically undergo detailed imaging and multidisciplinary evaluation before surgery.

Preoperative evaluation often includes:

  • pancreas-protocol CT imaging

  • CT imaging of the chest

  • MRI or MRCP in selected cases

  • endoscopic ultrasound with biopsy when needed

These studies help determine tumor location, relationship to nearby blood vessels, and overall surgical resectability.

Recovery After Distal Pancreatectomy

Recovery after distal pancreatectomy requires careful postoperative monitoring and coordinated multidisciplinary care.

Hospital stay typically ranges from 3–6 days, depending on the complexity of the operation and the patient’s overall health.

Potential postoperative issues include:

  • pancreatic fistula

  • bleeding

  • infection

  • delayed gastric emptying (less common than with Whipple surgery)

  • changes in glucose metabolism

Enhanced recovery pathways and experienced perioperative teams help support safe recovery.

Why Experience Matters in Pancreatic Surgery

Surgery involving the pancreas requires specialized expertise in hepatopancreatobiliary surgery and multidisciplinary cancer care.

Outcomes following pancreatic surgery are closely associated with surgeon experience, institutional infrastructure, and coordinated perioperative care.

Treatment by surgeons with focused expertise in pancreatic and HPB surgery helps optimize oncologic outcomes while minimizing operative risk.

Consultation and Referral

For Patients

Individuals seeking evaluation for pancreatic tumors of the body or tail — including new diagnoses or second opinions — may Request a Consultation to discuss individualized treatment planning and surgical options.

For Referring Physicians

Physicians wishing to refer a patient or discuss complex pancreatic disease may visit For Physicians for direct referral pathways and coordinated case review.